Association of Obesity With Prostate Specific Antigen and Prostate Specific Antigen Velocity in Healthy Young Men

Journal of Urology

Volumn 179, Issue 3, 2008, Pages 886-891

  Chang, In Ho ^a   Han, Jun Hyun ^a   Ahn, Seung Hyun ^a  

^a Korea Electric Power Research Institute (KEPRI)   (South Korea)

Author keywords

bias; Korea; obesity; prostate; prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIVARIATE ANALYSIS; BODY MASS; CONTROLLED STUDY; FLOW RATE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MULTIVARIATE ANALYSIS; OBESITY; PREDICTION; PRIORITY JOURNAL; WEIGHT CHANGE;

ADULT; AGE FACTORS; BODY MASS INDEX; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSTATE-SPECIFIC ANTIGEN;

EID: 39149119948     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.10.066     Document Type: Article

References (20)

1. Kim D.M., Ahn C.W., and Nam S.Y. Prevalence of obesity in Korea. Obes Rev 6 (2005) 117
2. Deurenberg P., Yap M., and van Staveren W.A. Body mass index and percent body fat: a meta-analysis among different ethnic groups. Int J Obes Relat Metab Disord 22 (1998) 1164
3. Freedland S.J., Aronson W.J., Kane C.J., Presti Jr. J.C., Amling C.L., Elashoff D., et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 22 (2004) 446
4. Freedland S.J., Terris M.K., Platz E.A., and Presti Jr. J.C. Body mass index as a predictor of prostate cancer: development versus detection on biopsy. Urology 66 (2005) 108
5. Kristal A.R., Chi C., Tangen C.M., Goodman P.J., Etzioni R., and Thompson I.M. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer 106 (2006) 320
6. Carter H.B., Morrell C.H., Pearson J.D., Brant L.J., Plato C.C., Metter E.J., et al. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. Cancer Res 52 (1992) 3323
7. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157
8. Thompson I.M., Pauler D.K., Goodman P.J., Tangen C.M., Lucia M.S., Parnes H.L., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 350 (2004) 2239
9. Goluboff E.T., Heitjan D.F., DeVries G.M., Katz A.E., Benson M.C., and Olsson C.A. Pretreatment prostate specific antigen doubling times: use in patients before radical prostatectomy. J Urol 158 (1997) 1876
10. Egawa S., Arai Y., Tobisu K., Kuwao S., Kamoto T., Kakehi Y., et al. Use of pretreatment prostate specific antigen doubling time to predict outcome after radical prostatectomy. Prostate Cancer Prostatic Dis 3 (2000) S11
11. D'Amico A.V., Chen M.H., Roehl K.A., and Catalona W.J. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351 (2004) 125
12. Ku J.H., Kim M.E., Lee N.K., Park Y.H., and Ahn J.O. Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men. Urology 61 (2003) 132
13. Baillargeon J., Pollock B.H., Kristal A.R., Bradshaw P., Hernandez J., Basler J., et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 103 (2005) 1092
14. Hutterer G., Perrotte P., Gallina A., Walz J., Jeldres C., Traumann M., et al. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. Eur J Cancer 43 (2007) 1180
15. Bañez L.L., Hamilton R.J., Vollmer R.T., Moul J.W., Amling C.L., Kane C.J., et al. Can hemodilution explain the lower PSA concentrations among obese men?. J Urol 177 suppl (2007) 468 abstract 1418
16. Preston D.M., Levin L.I., Jacobson D.J., Jacobsen S.J., Rubertone M., Holmes E., et al. Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology 56 (2000) 812
17. Ahn J.O., and Ku J.H. Relationship between serum prostate-specific antigen levels and body mass index in healthy younger men. Urology 68 (2006) 570
18. Muller M., den Tonkelaar I., Thijssen J.H., Grobbee D.E., and van der Schouw Y.T. Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol 149 (2003) 583
19. Messerli F.H., Sundgaard-Riise K., Reisin E., Dreslinski G., Dunn F.G., and Frohlich E. Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med 74 (1983) 808
20. Carter H.B., Ferrucci L., Kettermann A., Landis P., Wright E.J., Epstein J.I., et al. Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst 98 (2006) 1521